Li Runting, Zhao Yuanli, Chen Xiaolin, Hao Qiang
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
J Inflamm Res. 2022 Nov 28;15:6481-6494. doi: 10.2147/JIR.S386558. eCollection 2022.
This study aimed to explore the relationship between white blood cells (WBCs) at admission and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH).
We analyzed data from patients with aSAH between January 2015 and September 2021 who were included in the LongTEAM (Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage) registry study. WBC is classified into four groups according to the quartile. We used the logistic model for in-hospital complications, mortality, modified Rankin scale (mRS) at discharge and 90 days to examine the relationship between WBC and clinical outcomes. We used WBC levels near odds ratio (OR) = 1 (Q1) in restricted cubic splines as the reference to evaluate whether there is a nonlinear relationship between WBC and clinical outcomes. Another Kaplan-Meier method was used to analyze the relationship between WBC levels and the risk of developing pneumonia.
Of the 988 patients included, the results showed that compared with patients in the Q1 group, patients in the highest quartile (Q4) had an increased incidence of 90-day unfavorable outcomes after adjusting the confounders (adjusted OR = 1.81, 95% CI = 1.02-3.20, p = 0.042), which may be caused by the increased incidence and risk of pneumonia (adjusted OR = 2.06, 95% CI = 1.30-3.29, p = 0.002; adjusted hazard ratio [HR]=1.63, 95% CI = 1.13-2.36, p < 0.001). The restricted cubic spline indicated that the incidence of developing pneumonia and 90-day unfavorable outcomes rises with increasing WBC levels (p for nonlinear = 0.135 and 0.113).
Patients with higher WBC at admission were associated with an increased incidence of 90-day unfavorable outcomes, which might be related to pneumonia.
本研究旨在探讨动脉瘤性蛛网膜下腔出血(aSAH)患者入院时白细胞(WBC)与临床结局之间的关系。
我们分析了2015年1月至2021年9月期间纳入LongTEAM(急诊动脉瘤性蛛网膜下腔出血的长期预后)注册研究的aSAH患者的数据。根据四分位数将WBC分为四组。我们使用逻辑模型来研究WBC与住院并发症、死亡率、出院时及90天时的改良Rankin量表(mRS)之间的关系。我们将受限立方样条中接近比值比(OR)=1(Q1)的WBC水平作为参考,以评估WBC与临床结局之间是否存在非线性关系。另一种Kaplan-Meier方法用于分析WBC水平与发生肺炎风险之间的关系。
在纳入的988例患者中,结果显示,在调整混杂因素后,与Q1组患者相比,最高四分位数(Q4)组患者90天不良结局的发生率增加(调整后OR = 1.81,95%CI = 1.02 - 3.20,p = 0.042),这可能是由于肺炎的发生率和风险增加所致(调整后OR = 2.06,95%CI = 1.30 - 3.29,p = 0.002;调整后风险比[HR]=1.63,95%CI = 1.13 - 2.36,p < 0.001)。受限立方样条表明,发生肺炎的发生率和90天不良结局随WBC水平升高而增加(非线性p值分别为0.135和0.113)。
入院时WBC较高的患者90天不良结局的发生率增加,这可能与肺炎有关。